WHO ICTRP trial
Metered dose aerosol for inhalation in patients with mild and moderate…
CTRI/2016/02/006600 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2016/02/006600 |
|---|---|
| Public title | Metered dose aerosol for inhalation in patients with mild and moderate persistent bronchial asthma. |
| Scientific title | International multicenter open label randomized comparative study on the efficacy and safety of Fluzon 250 HFA metered dose aerosol for inhalation (Midas Care Pharmaceutical Pvt. Ltd., India) and Flixotide®, metered dose aerosol for inhalation (GlaxoSmithKline Pharmaceuticals S.A., Spain/Poland) in… |
| Primary sponsor | Rus Biopharm LLC |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India;Russian Federation |
| Conditions | Health Condition 1: null- Mild and moderate persistent bronchial asthma |
| Interventions | Intervention1: Salmeterol plus Fluticasone Propionate Test Drug Fluzon 250 HFA International Non-Proprietary Name Fluticasone Propionate : Dose 1 inhalation 2 times a day (a total dose of Fluticasone propionate of 500 µg/day) Mode of… |
| Registration date | Feb 2, 2016 |
| Target size | 120 |
| Secondary IDs | Protocol No. FLUZON 08 2015 Version 1.0 Dated 10 Aug 2015 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: